Akari Therapeutics PLC (AKTX): Akari Therapeutics to Host Investor and...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	31
Posts	3757
Boards Moderated	0
Alias Born	01/29/2012

Titan V

Re: None

Monday, 12/04/2017 4:21:57 PM

Monday, December 04, 2017 4:21:57 PM

Akari Therapeutics to Host Investor and Analyst Event During the 59th American Society of Hematology Meeting

Company to webcast event December 10, 2017, at 8:00 p.m. ET

https://globenewswire.com/news-release/2017/12/04/1220266/0/en/Akari-Therapeutics-to-Host-Investor-and-Analyst-Event-During-the-59th-American-Society-of-Hematology-Meeting.html

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AKTX News

Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm • PR Newswire (US) • 03/15/2024 04:53:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2024 09:25:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 09:24:24 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 09:57:28 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 01:34:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:28:34 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/09/2024 10:25:48 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/04/2024 05:34:21 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:56:38 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:49:19 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:58:40 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:41:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:30:25 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/01/2023 01:00:23 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 01:00:06 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/27/2023 08:15:28 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/20/2023 09:00:14 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 08:29:21 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 08:28:24 PM
Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 10/20/2023 08:23:50 PM

More AKTX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover